Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Early Stage NSCLC
NCT01342770Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Apr 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Apr 2011; status: terminated.
02
Drugs
pioglitazone
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01342770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01342770.